ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Observational Cohort Study in Poland.

Karolina Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.